Pholedrine
| Clinical data | |
|---|---|
| Trade names | Paredrinol, Presoitan, Pulsotyl, Veritain, Veritol |
| Other names | 4-Hydroxy-N-methylamphetamine; 4-HMA; 4-Hydroxymethamphetamine; para-Hydroxymethamphetamine; PHMA; Hydroxymethamphetamine |
| Routes of administration | Topical (ocular) |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.006.114 |
| Chemical and physical data | |
| Formula | C10H15NO |
| Molar mass | 165.236 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (verify) | |
Pholedrine, also known as 4-hydroxy-N-methylamphetamine and sold under the brand names Paredrinol, Pulsotyl, and Veritol among others, is a sympathomimetic drug used in topical eye drops to dilate the pupil.[1][2][3] It can be used to diagnose Horner's syndrome.[3]
In 2004, it remained marketed only in Germany.[1]
- ^ a b Schweizerischer Apotheker-Verein (2004). Index Nominum: International Drug Directory. Medpharm Scientific Publishers. p. 969. ISBN 978-3-88763-101-7. Retrieved 30 August 2024.
- ^ "Pholedrine". National Library of Medicine. Retrieved 24 June 2023.
- ^ a b Bates AT, Chamberlain S, Champion M, Foley L, Hughes E, Jani B, et al. (February 1995). "Pholedrine: a substitute for hydroxyamphetamine as a diagnostic eyedrop test in Horner's syndrome". Journal of Neurology, Neurosurgery, and Psychiatry. 58 (2): 215–217. doi:10.1136/jnnp.58.2.215. PMC 1073320. PMID 7876854.